Oncology & Cancer

DDX41 and its unique contribution to myeloid leukemogenesis

In an editorial paper published in Oncotarget titled, "DDX41 and its unique contribution to myeloid leukemogenesis," researcher Hirotaka Matsui from the National Cancer Center Hospital in Tokyo, Japan, and Kumamoto University ...

page 1 from 36